← ANALYSTS · TIPRANKS
Luca Issi · RBC Capital
Hits
39%
156 of 402 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
−2.1%
Over a year after the rating, TipRanks’ measure
Our companies rated now
25
Buy / hold / sell: 14 / 11 / 0
Upside of the analyst’s targets
+114.1%
Average over 25 current targets, to the last price
The market’s answer to the ratings
+12.8%
Day-0 move against SPY in the rating’s direction, average over 13 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 16on TipRanks 21:45 | MRNAQQQSPYModerna · $94.4B | Reiterated | Hold | $130 | −40.4% | after the close | ↗ |
| Oct 8on TipRanks 21:45 | MRNAQQQSPYModerna · $94.4B | Reiterated | Hold | $130 | −40.4% | +13.6%next day −4.9% · 5 days −1.1% | ↗ |
| Oct 8on TipRanks 21:45 | BMRNBioMarin Pharmaceutical · $10.8B | Reiterated | Hold | $62.00 | +13.4% | −0.8%next day +1.1% · 5 days +1.8% | ↗ |
| Oct 8on TipRanks 21:45 | IONSIonis Pharmaceuticals · $7.0B | Reiterated | Buy | $85.00 | +98.0% | +4.0%next day −3.5% · 5 days −3.2% | ↗ |
| Oct 8on TipRanks 21:45 | ARGXArgenx Se · $51.7B | Reiterated | Buy | $1,100 | +34.3% | +0.2%next day −1.5% · 5 days +1.3% | ↗ |
| Oct 8on TipRanks 21:45 | RAREIWMUltragenyx Pharmaceutical · $1.5B | Reiterated | Hold | $19.00 | +30.7% | +0.6%next day −1.1% · 5 days −4.1% | ↗ |
| Oct 8on TipRanks 21:45 | ASNDAscendis Pharma · $13.9B | Reiterated | Buy | $290 | +28.7% | +2.3%next day −0.9% · 5 days +0.2% | ↗ |
| Oct 8on TipRanks 21:45 | AGIOIWMAgios Pharma · $1.8B | Reiterated | Hold | $32.00 | +2.2% | −0.9%next day −3.1% · 5 days +0.4% | ↗ |
| Oct 8on TipRanks 21:45 | BBIOBridgeBio Pharma · $12.4B | Reiterated | Buy | $100 | +50.6% | −0.1%next day +0.7% · 5 days +3.6% | ↗ |
| Oct 8on TipRanks 08:55 | ALNYQQQAlnylam Pharma · $31.3B | Reiterated | Buy | $350 → $345−1.4% | +48.8% | +0.5%next day +3.0% · 5 days +4.5% | ↗ |
| Oct 8on TipRanks 08:55 | AMGNQQQSPYAmgen · $235B | Reiterated | Buy | $400 → $430+7.5% | −0.6% | −0.9%next day +1.2% · 5 days +6.8% | ↗ |
| Oct 6on TipRanks Oct 7 05:11 | CRBUIWMCaribou Biosciences · $50M | Downgrade | Hold | $10.00 → $1.00−90.0% | +113.2% | −5.2%next day −45.4% · 5 days −58.5% | ↗ |
| Oct 2on TipRanks Sep 29 15:06 | QUREuniQure · $1.5B | Assigned | Buy | $65.00 → $48.00−26.2% | +120.4% | −37.1%next day −1.2% · 5 days −7.9% | ↗ |
| Sep 16on TipRanks 06:15 | SLDBIWMSolid Biosciences · $615M | Initiated | Buy | $18.00 | +225.5% | +4.6%next day +0.6% · 5 days −10.1% | ↗ |
| Sep 8on TipRanks Sep 9 07:30 | DYNIWMDyne Therapeutics · $2.9B | Reiterated | Buy | $35.00 → $30.00−14.3% | +110.5% | −15.8%next day −5.0% · 5 days −10.7% | ↗ |
| Sep 3on TipRanks 07:50 | RAREIWMUltragenyx Pharmaceutical · $1.5B | Downgrade | Hold | $40.00 → $19.00−52.5% | +30.7% | −45.1%next day +3.4% · 5 days −2.6% | ↗ |
| Aug 30on TipRanks Aug 31 07:25 | ARWRArrowhead Pharmaceuticals · $8.2B | Reiterated | Buy | $100 | +78.9% | −2.7%next day +1.1% · 5 days +3.4% | ↗ |
| Aug 19on TipRanks 11:21 | MRNAQQQSPYModerna · $94.4B | Reiterated | Hold | $45.00 → $130+188.9% | −40.4% | +176.8%next day −22.7% · 5 days −13.8% | ↗ |
| Aug 17on TipRanks Aug 18 08:10 | ARGXArgenx Se · $51.7B | Reiterated | Buy | $1,025 → $1,100+7.3% | +34.3% | +16.5%next day +1.2% · 5 days +3.5% | ↗ |
| Aug 14on TipRanks 10:25 | BBIOBridgeBio Pharma · $12.4B | Reiterated | Buy | $100 | +50.6% | −1.5%next day +0.5% · 5 days +3.4% | ↗ |
| Aug 13on TipRanks Aug 17 05:56 | CRBUIWMCaribou Biosciences · $50M | Reiterated | Buy | $10.00 | +2,032.2% | −6.0%next day −1.7% · 5 days +2.0% | ↗ |
| Aug 13on TipRanks Aug 14 08:35 | ASNDAscendis Pharma · $13.9B | Reiterated | Buy | $280 → $290+3.6% | +28.7% | −4.3%next day +1.1% · 5 days +5.4% | ↗ |
| Aug 12on TipRanks Aug 13 07:45 | LXEOIWMLexeo Therapeutics, Inc. · $227M | Reiterated | Buy | $20.00 | +657.6% | +1.6%next day +1.2% · 5 days +10.7% | ↗ |
| Aug 12on TipRanks Aug 13 07:45 | ALLOIWMAllogene Therapeutics · $463M | Reiterated | Buy | $9.00 | +587.0% | −2.6%next day −5.0% · 5 days +8.2% | ↗ |
| Aug 7on TipRanks 21:45 | KRROIWMKorro Bio · $137M | Reiterated | Hold | $10.00 | +17.8% | +1.8%next day −0.9% · 5 days −2.5% | ↗ |
| Aug 6on TipRanks Aug 7 07:26 | RGNXIWMRegenXBio · $473M | Reiterated | Buy | $19.00 | +174.4% | +7.6%next day −5.6% · 5 days −6.7% | ↗ |
| Aug 6on TipRanks Aug 7 07:26 | NTLAIWMIntellia Therapeutics · $1.6B | Reiterated | Hold | $15.00 | +31.3% | +2.6%next day +5.6% · 5 days +4.0% | ↗ |
| Aug 5on TipRanks Aug 6 07:01 | EDITIWMEditas Medicine · $375M | Reiterated | Hold | $4.00 | +70.2% | −0.5%next day +5.6% · 5 days +2.9% | ↗ |
| Aug 5on TipRanks 07:42 | BEAMIWMBeam Therapeutics · $2.6B | Reiterated | Hold | $26.00 | +10.8% | −4.3%next day +0.8% · 5 days −1.7% | ↗ |
| Aug 5on TipRanks 07:40 | AMGNQQQSPYAmgen · $235B | Reiterated | Buy | $370 → $400+8.1% | −7.5% | +4.8%next day −0.6% · 5 days +1.7% | ↗ |
| Aug 3on TipRanks Aug 5 21:45 | CRSPIWMCrispr Therapeutics AG · $5.0B | Reiterated | Hold | $50.00 | +1.5% | +1.9%next day +5.3% · 5 days +5.9% | ↗ |
| Jul 30on TipRanks Jul 31 10:36 | WVEIWMWave Life Sciences · $629M | Reiterated | Buy | $15.00 | +379.2% | −2.5%next day −5.1% · 5 days +0.9% | ↗ |
| Jul 30on TipRanks Jul 31 10:36 | AGIOIWMAgios Pharma · $1.8B | Reiterated | Hold | $32.00 | +2.2% | −8.1%next day −9.1% · 5 days −6.1% | ↗ |
| Jul 30on TipRanks Jul 31 08:18 | ALNYQQQAlnylam Pharma · $31.3B | Assigned | Buy | $445 → $350−21.3% | +51.0% | −30.0%next day −0.7% · 5 days +1.6% | ↗ |
| Jun 2on TipRanks Jun 3 21:45 | FULCIWMFulcrum Therapeutics · $280M | Reiterated | Hold | $10.00 → $4.00−60.0% | +9.6% | −51.2%next day +3.2% · 5 days +15.1% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗